Kronos Bio

$9.89 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Kronos Bio

Kronos Bio, Inc. operates as a biotechnology company. The Company discovers and develops therapies that modulate historically recalcitrant cancer targets. Kronos Bio serves customers in worldwide.

Stock Analysis

last close $10
1-mo return -29.6%
3-mo return -39.4%
avg daily vol. 207.35T
52-week high 33.39
52-week low 9.96
market cap. $602M
forward pe -
annual div. -
roe -75.6%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 67.3%
baraka

Subscribe now for daily local and international financial news

Subscribe